| Developing a predictive model for clinical outcomes of advanced non-small cell lung cancer patients treated with nivolumab W Park, D Kwon, D Saravia, A Desai, F Vargas, M El Dinali, J Warsch, ... Clinical lung cancer 19 (3), 280-288. e4, 2018 | 54 | 2018 |
| Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study RT Swords, D Azzam, H Al-Ali, I Lohse, CH Volmar, JM Watts, A Perez, ... Leukemia research 64, 34-41, 2018 | 54 | 2018 |
| Incendios forestales en Chile: causas, impactos y resiliencia ME González, R Sapiains, S Gómez-González, R Garreaud, A Miranda, ... Centro de Ciencia del Clima y la Resiliencia (CR) 2, 84, 2020 | 44 | 2020 |
| Complications of intrathecal chemotherapy in adults: single-institution experience in 109 consecutive patients DM Byrnes, F Vargas, C Dermarkarian, R Kahn, D Kwon, J Hurley, ... Journal of oncology 2019, 2019 | 35 | 2019 |
| An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma JP Alderuccio, L Arcaini, MP Watkins, AW Beaven, G Shouse, N Epperla, ... Blood advances 6 (7), 2035-2044, 2022 | 18 | 2022 |
| Acute leukemia in adult Hispanic Americans: a large-population study R Swords, J Sznol, R Elias, J Watts, A Zelent, E Martin, F Vargas, ... Blood cancer journal 6 (10), e484-e484, 2016 | 18 | 2016 |
| Inhibition of the PI3K/AKT/mTOR pathway leads to down-regulation of c-Myc and overcomes resistance to ATRA in acute myeloid leukemia RT Swords, T Schenk, S Stengel, VS Gil, KR Petrie, A Perez, R Ana, ... Blood 126 (23), 1363, 2015 | 16 | 2015 |
| Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better? G Campuzano‐Zuluaga, Y Deutsch, M Salzberg, A Gomez, F Vargas, ... American journal of hematology 91 (3), 277-282, 2016 | 9 | 2016 |
| Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular … CD Davila, F Vargas, KHG Huang, T Monaco, A Dimou, J Rangaswami, ... Platelets 26 (7), 651-656, 2015 | 9 | 2015 |
| In acute myeloid leukemia (AML), targeting the histone methyltransferase EZH2 promotes differentiation, impairs clonogenic survival and augments the anti-leukemic effects of … RT Swords, A Perez, A Rodriguez, JM Watts, T Schenk, F Vargas, R Elias, ... Blood 126 (23), 3786, 2015 | 8 | 2015 |
| Concomitant typhlitis and Clostridium difficile colitis developed after first R-CHOP chemotherapy in a non-Hodgkin lymphoma patient P Junpaparp, S Buppajarntham, FV Madueno, G Varadi Case Reports 2013, bcr2013008894, 2013 | 8 | 2013 |
| The Small Molecule Img-98, a Potent and Selective Inhibitor of the Lysine Demethylase Lsd-1, Effectively Augments the Pro-Differentiation Effects of ATRA in a Pre-Clinical … AZ Ronan T. Swords, Aymee Perez, Ana Rodriguez, Justin M. Watts, Fernando ... Blood 126 (23), 460, 2015 | 5 | 2015 |
| A Patient-Specific Ex Vivo Screening Platform for Personalized Acute Myeloid Leukemia (AML) Therapy D Azzam, CH Volmar, AA Hassan, A Perez, JM Watts, F Vargas, R Elias, ... Blood, The Journal of the American Society of Hematology 126 (23), 1352-1352, 2015 | 5 | 2015 |
| Incidence of neurological complications secondary to intrathecal chemotherapy used as either prophylaxis or treatment of leptomeningeal carcinomatosis DM Byrnes, CR Dermarkarian, R Kahn, D Kwon, F Vargas, J Hurley, ... Blood 128 (22), 5973, 2016 | 4 | 2016 |
| P3. 02c-081 Complete Blood Count Parameters as Predictive Factors in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab: Topic: IT Biomarkers D Saravia, B Laderian, W Park, A Desai, F Vargas, R Elias, S Warsch, ... Journal of Thoracic Oncology 12 (1), S1327, 2017 | 1 | 2017 |
| Early Detection of Myelodysplastic Syndromes: Maximizing the Utility of Automated Hematology YL Carattini, T Bradley, F Vargas, JM Watts, JR Chapman, ... Blood 128 (22), 5527, 2016 | 1 | 2016 |
| The BET Bromodomain Inhibitors EP11313 and EP11336 Have Potent Anti-Leukemic Activity in Acute Myeloid Leukemia (AML) and Augment the Effects of All-Trans-Retinoic Acid (AtRA … RT Swords, S Brothers, N Ayad, A Perez, JM Watts, F Vargas, R Elias, ... Blood, The Journal of the American Society of Hematology 126 (23), 2552-2552, 2015 | 1 | 2015 |
| Statin use and its effects on skeletal related events in patients with multiple myeloma FMV Madueno, A Benyounes, G King, KHG Huang, G Varadi Blood 124 (21), 5774, 2014 | 1 | 2014 |
| B-Lymphoblastic Leukemia/Lymphoma F Vargas, B Shah Handbook of Hematologic Malignancies, 155, 2020 | | 2020 |
| ABCL-248: Representation of Race, Gender, Age, HIV Status, and Treated Viral Hepatitis in Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of Enrollment Demographics in … RO Uba, S Boisclair, A Brahim, R Wilkinson, F Vargas, J Chavez, ... Clinical Lymphoma Myeloma and Leukemia 20, S268-S269, 2020 | | 2020 |
